84 Kwon SJ VW, et al. Lymphadenectomy for adenocarcinoma of the gas- troesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surgl Oncol 2006;14:306-316. 12. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stom- ach or gastroesophageal junction. N Engl J Med 2001;345:725- 730. 13. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20. 14. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resec- tion in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-646. 15. Fukuda N, Sugiyama Y, Midorikawa A, Mushiake H. Prognos- tic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 2009;33:2378-2382. 16. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: impact on staging and sur- vival of gastic cancer. Eur J Surg Oncol 2008;34:519-524. 17. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-552. 18. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimizes patient staging in colorectal cancer. Br J Cancer 2009;100:1530-1533. 19. Peschaud F, Benoist S, Julié C, Beauchet A, Penna C, Rougier P, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 2008;248:1067-1073. 20. Van der Wal BC, Butzelaar RM, van der Meij S, Boermeeste MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast can- cer. Eur J Surg Oncol 2002;28:481-489. 21. Lemmens VE, Dassen AE, van der Wurff AA, Coebergh JW, Bosscha K. Lymph node examination among patients with gastric cancer: Variation between department of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol 2011;37:488-496. 22. Ha TK, Kwon SJ. Subclassification of stage IV gastric cancer according to the presence of distant metastasis (IVa and IVb). J Korean Gastric Cancer Assoc 2006;6:173-180. 23. Park JM, Park SS, Mok YJ, Kim CS. pN3M0 gastric cancer: the category that allows the sub-classification of stage IV gastric cancer (IVa and IVb). Ann Surg Oncol 2007;14:2535-2542. 24. Li C, Yan M, Chen J, Xiang M, Zhu ZG, Lin YZ. Prognostic in- fluence of sub-stages according to pTNM categories in patients with stage IV gastric cancer. J Surg Oncol 2009;99:324-328. 25. An JY, Ha TK, Noh JH, Sohn TS, Kim S. Proposal to subclas- sify stage IV gastric cancer into IVa, IVb, and IVM. Arch Surg 2009;144:38-45. 26. Kodera Y, Nakanishi H, Ito S, Nakao A. Clinical significance of isolated tumor cells and micrometastases in patients with gas- tric carcinoma. Gan To Kagaku Ryoho 2007;34:817-823. 27. Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, et al. Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010;34:563-568. 28. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy im- prove survival? Ann Surg Oncol 2008;15:2684-2691. 29. Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D. Perito- neal lavage cytology in patients with oesophagogastric adeno- carcinoma. Br J Surg 2008;95:721-726. 30. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg 2010;17:3077-3079. 31. Hassan HA, Sharma VK, Raufman JP. Changing trends in gastric carcinoma at a university medical center: a twelve-year retrospective analysis. J Clin Gastroenterol 2001;32:37-40. 32. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-614. 33. Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999;80:834-842. 34. Rüdiger Siewert J, Feith M, Werner M, Stein HJ. Adenocar- cinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361. 35. Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center